Seminar around the best ways for small life science companies to raise capital to generate big value

lifesciencebannerOn Thursday 26 January 2017 at 3-6 pm you and your life science colleagues are invited to AstraZeneca Gothenburg for an open, engaging and informative discussion around the best ways for small life science companies to raise capital to generate big value. This is part one of a two-part collaboration hosted by Nasdaq, AstraZeneca BioVentureHub and Sahlgrenska Science Park. Part two will take place at Sahlgrenska Science Park later in the spring.

Outline agenda

  • Registration and welcome
  • Trends in biotech funding
  • Inside the head of a life science investor
  • Panel discussion: What’s the best way for a small life science company to raise capital to generate big value?
  • Networking, refreshments and bell ringing
  • Surgery session for companies who are interested in a deeper dive with Nasdaq advisers (limited number of spaces and separate registration)
  • Presenters / panelists

  • Carl Bennet (Carl Bennet AB)
  • Adam Kostyal (Nasdaq)
  • Erik Gatenholm (Cellink)
  • Homan Panahi (Vator Securities)
  • Johannes Hulthe (Antaros Medical)
  • Charlotta Gummeson (Sahlgrenska Science Park)
  • Klementina Österberg (GU Ventures)
  • Magnus Björsne (AstraZeneca BioVentureHub)
  • To pre-register or to find out more, please send an email to bioventurehub@astrazeneca.com